Detalhe da pesquisa
1.
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Acta Oncol
; 61(10): 1263-1267, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307938
2.
Higher number of steps and breaks during sedentary behaviour are associated with better lipid profiles.
BMC Public Health
; 21(1): 629, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789632
3.
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.
Acta Oncol
; 59(3): 310-314, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564175
4.
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay.
Int J Cancer
; 128(10): 2382-92, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20658534
5.
[Are immunological treatments beneficial for malignant melanoma of the skin?]. / Hyödyttävätkö ihomelanooman immunologiset hoidot?
Duodecim
; 126(14): 1701-10, 2010.
Artigo
em Fi
| MEDLINE | ID: mdl-20804089
6.
Carboplatin and vinorelbine combined with subcutaneous interleukin-2 in metastatic melanoma with poor prognosis.
Anticancer Res
; 29(5): 1755-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19443399
7.
ECCO essential requirements for quality cancer care: Melanoma.
Crit Rev Oncol Hematol
; 122: 164-178, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458785
8.
Serum angiogenin levels predict treatment response in patients with stage IV melanoma.
Clin Exp Metastasis
; 24(7): 567-74, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17762972
9.
The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
Cancer Genet Cytogenet
; 176(1): 54-7, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17574964
10.
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Clin Cancer Res
; 11(14): 5158-66, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16033831
11.
Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
Melanoma Res
; 15(4): 291-6, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16034308
12.
Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
Melanoma Res
; 21(5): 431-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21730877
13.
A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma.
Melanoma Res
; 20(4): 318-25, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20375744
14.
Serum VEGF-C is associated with metastatic site in patients with malignant melanoma.
Acta Oncol
; 46(5): 678-84, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17562445